Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s displayed system revision/version has been incremented from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:43:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:28:41.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Updated internal site revision from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:25.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed. No substantive changes to the study information or documents are visible.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:44.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A new site revision note (v3.4.2) was added and older notices/revisions (including a government funding status notice and revision v3.4.1) were removed. There is no impact on the study content or the information presented about the trial.
    Difference
    0.4%
    Check dated 2026-02-11T14:20:58.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting information timeliness and response to inquiries. Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:27:43.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.